RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of UTHR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very red day for United Therapeutics Corporation stock price after a -5.57% fall in the Thursday trading session
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The United Therapeutics Corporation stock price fell by -5.57% on the last day (Thursday, 28th Mar 2024) from $243.27 to $229.72. During the last trading day the stock fluctuated 6.30% from a day low at $229.14 to a day high of $243.57. The price has been going up and down for this period, and there has been a -3.52% loss for the last 2 weeks. Volume has increased on the last day by 488 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $256.03 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $223.75 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.77% during the next 3 months and, with a 90% probability hold a price between $245.63 and $279.20 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

UTHR Signals & Forecast

There are few to no technical positive signals at the moment. The United Therapeutics Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $239.52 and $230.03. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -7.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for United Therapeutics Corporation stock

United Therapeutics Corporation finds support from accumulated volume at $225.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $14.43 between high and low, or 6.30%. For the last week, the stock has had daily average volatility of 4.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UTHR) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect United Therapeutics Corporation to open at $234.14, and during the day (based on 14 day Average True Range), to move between $222.33 and $237.11, which gives a possible trading interval of +/-$7.39 (+/-3.22%) up or down from last closing price. If United Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 6.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $231.92 (0.96%) than the support at $225.64 (1.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is United Therapeutics Corporation stock A Buy?

The United Therapeutics Corporation stock holds several negative signals and despite the positive trend, we believe United Therapeutics Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.560 Sell Candidate Downgraded

Predicted Opening Price for United Therapeutics Corporation of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$234.14 ( 1.93%) $229.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for UTHR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 248.57 8.21 %
R2 243.06 5.81 %
R1 239.66 4.33 %
Current price: 229.72
Support S1 228.63 -0.474 %
S2 225.23 -1.96 %
S3 219.71 -4.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 244.26 6.33 %
R2 235.78 2.64 %
R1 231.92 0.96 %
Current price 229.72
Support S1 225.64 -1.78%
S2 219.18 -4.59%
S3 214.16 -6.77%

FAQ

What is the symbol for United Therapeutics Corporation Stock and on which exchange is it traded?
The symbol for United Therapeutics Corporation is UTHR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell United Therapeutics Corporation Stock?
The United Therapeutics Corporation stock holds several negative signals and despite the positive trend, we believe United Therapeutics Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy United Therapeutics Corporation Stock?
United Therapeutics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy United Therapeutics Corporation Stock.

What's the current price of United Therapeutics Corporation Stock?
As of the end of day on the 2024-03-28, the price of an United Therapeutics Corporation (UTHR) share was $229.72.

What is the 52-week high and low for United Therapeutics Corporation Stock?
The 52-week high for United Therapeutics Corporation Stock is $261.48 and the 52-week low is $204.44.

What is the market capitalization of United Therapeutics Corporation Stock?
As of the 2024-03-28, the market capitalization of United Therapeutics Corporation is 10.81B.

When is the next earnings date for United Therapeutics Corporation?
The upcoming earnings date for United Therapeutics Corporation is May 01, 2024.
Click to get the best stock tips daily for free!

About United Therapeutics Corporation

United Therapeutics United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a... UTHR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT